CINF
38
-3
VLO
30
2
PRGO
36
4
LMT
49
4
AEP
51
6
UNP
55
2
PHM
68
3
MAC
74
3
MCD
65
2
TMO
52
-2
TSN
39
3
BAC
54
3
CVX
32
3
EMR
54
4
AEE
61
3
WM
73
2
CSCO
67
4
CA
14
10
AIZ
64
7
SJM
28
-8
CINF
38
-3
VLO
30
2
PRGO
36
4
LMT
49
4
AEP
51
6
UNP
55
2
PHM
68
3
MAC
74
3
MCD
65
2
TMO
52
-2
TSN
39
3
BAC
54
3
CVX
32
3
EMR
54
4
AEE
61
3
WM
73
2
CSCO
67
4
CA
14
10
AIZ
64
7
SJM
28
-8
Financhill
Back

Optimize Strategy Index ETF Vs. Kymera Therapeutics Industry Stock Comparison

Sell
46

OPTZ
Optimize Strategy Index ETF

Last Price:
29.17
Seasonality Move:
--
Buy
71

KYMR
Kymera Therapeutics

Last Price:
46.27
Seasonality Move:
65.72%
Sell
46
Optimize Strategy Index ETF (OPTZ) is a Sell

Is Optimize Strategy Index ETF a Buy, Sell or Hold?

  • The current Optimize Strategy Index ETF [OPTZ] share price is $29.19. The Score for OPTZ is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • OPTZ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

OPTZ Stock Price Chart

What is Optimize Strategy Index ETF's stock price today?

  • The Optimize Strategy Index ETF share price today is $29.19
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OPTZ is experiencing buying pressure, which is a positive indicator for future bullish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $49.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

OPTZ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.37 Buy
Relative Strength Index (14 RSI): 64.16 Buy
Chaikin Money Flow: 27934 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.94 - 28.84) Buy
Bollinger Bands (100): (26.52 - 28.1) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 59.12 Buy
Chaikin Money Flow: 317205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.81 - 49.49) Buy
Bollinger Bands (100): (34.86 - 47.92) Buy

OPTZ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.82 Buy
20-day SMA: 28.55 Buy
50-day SMA: 27.74 Buy
200-day SMA: 0 Buy
8-day EMA: 28.89 Buy
20-day EMA: 28.52 Buy
50-day EMA: 27.95 Buy
200-day EMA: 9.06 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.58 Buy
20-day SMA: 46.67 Buy
50-day SMA: 46.11 Buy
200-day SMA: 38.62 Buy
8-day EMA: 45.67 Buy
20-day EMA: 45.85 Buy
50-day EMA: 45.2 Buy
200-day EMA: 38.5 Buy

Optimize Strategy Index ETF Earnings Growth & OPTZ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

Optimize Strategy Index ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):